|
|
|
|
|
|||||||
|
Session 86
Poster Session
HCV Co-Infection: Treatment 4:30-6:30 pm 4E-F |
to view the poster for an abstract.| 650-M. | Mutations within the E2 and NS5A Protein in HIV-1-Positive Patients Infected with HCV Genotype 3a and Correlation with Treatment Response S. Bagaglio, C. Uberti Foppa, A. De Bona, R. Novati, A. Lazzarin*, and G. Morsica San Raffaele, Sci. Inst., Milan, Italy
| ||
| 651-M. | Multicenter, Randomized, Open-Label Study of the Safety and Efficacy of Interferon (IFN) M. Sulkowski*1, F. Felizarta2, C. Smith3, R. Berggren4, J. Slim5, D. Shoultz6, L. Ball7, R. Hudnall7, and D. Dieterich8 for the Hepatitis Resource Network Clinical Trials Group 1Johns Hopkins Univ., Baltimore, MD; 2Bakersfield, CA; 3North Gen. Hosp., New York, NY; 4Tulane Univ., New Orleans, LA; 5Newark, NJ; 6PPD Development, Wilmington, NC; 7Hepatitis Resource Network, Tacoma, WA; and 8New York Univ., New York
| ||
| 652-M. | Pegylated Interferon plus Ribavirin as Therapy for Chronic Hepatitis C in HIV-Infected Patients M. Pérez-Olmeda*, M. Núñez, M. Romero, J. González, A. Castro, J. R. Arribas, J. Pedreira, P. Barreiro, J. García-Samaniego, and V. Soriano Inst. de Salud Carlos III, Madrid, Spain
| ||
| 653-M. | Treatment of Chronic Hepatitis C: SHIRT (Spanish HIV Interferon Ribavirin Trial) M. Pérez-Olmeda*1, V. Asensi2, M. Romero1, M. Colmenero3, F. Sánchez-Montero4, A. Ochoa5, M. Santín6, J. Guardiola7, J. Blanch8, J. García-Samaniego1, and V. Soriano1 for The HCV/HIV Spanish Study Group 1Hosp. Carlos III, Madrid; 2Hosp. Central de Asturias, Oviedo; 3Hosp. Virgen de la Macarena, Sevilla; 4C. Hosp. de Cáceres; 5Hosp. Mutua de Tarrasa; 6Hosp. Bellvitge; 7Hosp. Sta. Creu i S. Pau; and 8Hosp. S. Camil, Barcelona, Spain
| ||
| 654-M. | The Effect of Interferon Therapy on Plasma MMP Activity in HIV/HCV Co-Infected Patients S. Hopkins*1, M. Hennessy2, P. Spiers2, S. Clarke1, M. Barry2, F. Mulcahy1, and C. Bergin1 1St. James's Hosp., Dublin and 2Trinity Coll. Dublin, UK
| ||
| 655-M. | Liver and Kidney Transplantation in HIV-Infected Patients: A Preliminary Multi-Site Experience M. Roland*1, P. Stock1, L. Carlson1, M. Ragni2, S. Rohal2, M. Keller3, B. Murphy3, J. Jacobson3, L. Kim-Schluger3, A. Humar4, T. Pruett5, C. Berg5, A. Lu6, W. Bennett 7, M. Allee7, K. Olthoff8, M. S. A. Kumar9, M. Gold9, A. Damask9, J. Light 10, and R. Redfield11 1Univ. of California, San Francisco; 2Univ. of Pittsburgh, PA; 3Mt. Sinai Med. Ctr., New York; 4Univ. of Minnesota, Minneapolis; 5Univ. of Virginia, Charlottesville; 6Georgetown Univ., Washington DC; 7 Legacy Good Samaritan Hosp., Portland, OR; 8Univ. of Pennsylvania, Philadelphia; 9 Hahnemann Univ., Philadelphia, PA; 10Washington Hosp. Ctr., Washington, DC; and 11Univ. of Maryland, College Park
|
